PEAHA
Asset Logo

Pepper Residential Securities Trust No. 30

๐Ÿ‡ฆ๐Ÿ‡บ ASX

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

N/A
Annual Growth

5 years average annual growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

0
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Class A1 Frn Mat 15-Jan-63 Min Cons $5Ht Nc

๐Ÿ“ˆ Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in PEAHA

0

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

N/A

๐Ÿ’ต Average investment amount

N/A

โฐ Last time a customer invested in PEAHA

N/A
PEAHA investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

๐Ÿ™‹ Legal gender of investors

Female

Male

Pearlers who invest in PEAHA also invest in...

Want more shares? Try these...

Pacific Edge Limited

PEB

Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. The firm is engaged in the development and commercialization of bladder cancer diagnostic and prognostic tests for patients presenting with hematuria or surveillance of recurrent disease. The firm operates through two segments: Commercial and Research. The Commercial segment is engaged in the sales, marketing, laboratory, and support operations to run the commercial businesses worldwide. The Research segment is engaged in the research and development of diagnostic and prognostic products for human cancer. The firm provides its suite of Cxbladder tests globally through its wholly owned laboratories in New Zealand and the United States. Its Cxbladder tests assist clinicians to safely de-intensify hematuria evaluation from low incidence populations; resolve diagnostic dilemmas and monitor patients for the recurrence of urothelial carcinoma. The company operates in New Zealand, Australia, Singapore, and the United States.

๐Ÿ“Š Share price

$0.10 AUD

๐Ÿงฌ BIOTECHNOLOGY

Find Out More

Perpetual Resources Ltd. engages in the development of coal mines through exploration interests. The company is headquartered in Melbourne, Victoria. The company went IPO on 2013-02-28. The Companyโ€™s principal activities consist of silica sands exploration of the Beharra Silica Sands Project, the Sargon Construction Sands Project and the Eneabba Project. Its flagship asset, the Beharra Project, is located approximately 300 kilometers (km) north of Perth and 96 km south of the port town of Geraldton in Western Australia, covering an area of approximately 49 square kilometers (km2). The Sargon Construction Sands project consists of a single exploration license, 70/5376, which covers a total land area of approximately 18 km2 and is located 45 km from Geraldton Port via the Brand Highway. The Eneabba North Project consists of a single exploration license, E70/5250, and covers a total land area of approximately 14 km2. Its Arrowsmith West project is located approximately 3.2 km west and south of Beharra silica sand project.

๐Ÿ™Œ Performance (5Yr p.a)

-11.11%

๐Ÿ“Š Share price

$0.02 AUD

โ›๏ธ MINING

Compare
Add to watchlist